Testing a new norovirus treatment in healthy adults
Part of Infections clinical trials.
This trial tests an investigational medicine called CDI-988 to see if it can prevent or treat norovirus infection. Healthy adults will be intentionally exposed to a mild norovirus strain to see how the medicine works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy adult between 18 and 49 years old
- You have a known secretor status (a genetic trait that affects norovirus susceptibility)
- You have not had norovirus or participated in norovirus research before
- You don't have chronic stomach or bowel problems
- You are not taking medicines that weaken the immune system
- You have a body weight above 45 kg and a BMI between 18 and 32
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug, EDI048, to see how well it works and how safe it is for treating cryptosporidium infection. It is for healthy volunteers who will be intentionally exposed to the infection under controlled conditions.
This study tests how a new medicine, PF-08065010, is handled by the body and how safe it is in healthy adults. It helps researchers find the right dose for future studies.
This trial tests a new drug called NTQ5082 in healthy people to see how safe it is and how the body processes it. If you qualify, you will help researchers understand the drug's effects before it is tested in patients with a disease.
This is an early-stage safety study testing a new experimental drug called REGN22044 in people with no serious health conditions. Researchers want to understand how safe the drug is, how well people tolerate it, and how the body processes it.
This trial tests a new medicine to see how the body handles it and whether it is safe. It is for healthy people, not for treating a disease, and helps researchers decide if the drug can move to the next stage of testing.
This study tests a new oral medication, VG290131, in healthy volunteers to see how the body processes it and if it is safe. It is an early-phase trial that requires participants to be in good health and follow specific rules about medications and lifestyle.
Hear when a new Norovirus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.